S&P 500   5,161.48 (-0.72%)
DOW   38,218.57 (-0.63%)
QQQ   441.81 (-0.80%)
AAPL   177.99 (+1.69%)
MSFT   424.83 (-0.72%)
META   516.07 (-1.36%)
GOOGL   159.82 (+0.26%)
AMZN   187.89 (-0.61%)
TSLA   172.19 (-1.38%)
NVDA   893.82 (-1.36%)
AMD   162.64 (-4.61%)
NIO   4.17 (-6.50%)
BABA   72.68 (-2.90%)
T   16.44 (+0.12%)
F   12.80 (-1.84%)
MU   125.00 (-1.97%)
GE   156.17 (-0.78%)
CGC   8.17 (+0.25%)
DIS   115.69 (-1.25%)
AMC   2.75 (-1.79%)
PFE   26.25 (-0.34%)
PYPL   65.51 (-0.44%)
XOM   123.08 (+1.06%)
S&P 500   5,161.48 (-0.72%)
DOW   38,218.57 (-0.63%)
QQQ   441.81 (-0.80%)
AAPL   177.99 (+1.69%)
MSFT   424.83 (-0.72%)
META   516.07 (-1.36%)
GOOGL   159.82 (+0.26%)
AMZN   187.89 (-0.61%)
TSLA   172.19 (-1.38%)
NVDA   893.82 (-1.36%)
AMD   162.64 (-4.61%)
NIO   4.17 (-6.50%)
BABA   72.68 (-2.90%)
T   16.44 (+0.12%)
F   12.80 (-1.84%)
MU   125.00 (-1.97%)
GE   156.17 (-0.78%)
CGC   8.17 (+0.25%)
DIS   115.69 (-1.25%)
AMC   2.75 (-1.79%)
PFE   26.25 (-0.34%)
PYPL   65.51 (-0.44%)
XOM   123.08 (+1.06%)
S&P 500   5,161.48 (-0.72%)
DOW   38,218.57 (-0.63%)
QQQ   441.81 (-0.80%)
AAPL   177.99 (+1.69%)
MSFT   424.83 (-0.72%)
META   516.07 (-1.36%)
GOOGL   159.82 (+0.26%)
AMZN   187.89 (-0.61%)
TSLA   172.19 (-1.38%)
NVDA   893.82 (-1.36%)
AMD   162.64 (-4.61%)
NIO   4.17 (-6.50%)
BABA   72.68 (-2.90%)
T   16.44 (+0.12%)
F   12.80 (-1.84%)
MU   125.00 (-1.97%)
GE   156.17 (-0.78%)
CGC   8.17 (+0.25%)
DIS   115.69 (-1.25%)
AMC   2.75 (-1.79%)
PFE   26.25 (-0.34%)
PYPL   65.51 (-0.44%)
XOM   123.08 (+1.06%)
S&P 500   5,161.48 (-0.72%)
DOW   38,218.57 (-0.63%)
QQQ   441.81 (-0.80%)
AAPL   177.99 (+1.69%)
MSFT   424.83 (-0.72%)
META   516.07 (-1.36%)
GOOGL   159.82 (+0.26%)
AMZN   187.89 (-0.61%)
TSLA   172.19 (-1.38%)
NVDA   893.82 (-1.36%)
AMD   162.64 (-4.61%)
NIO   4.17 (-6.50%)
BABA   72.68 (-2.90%)
T   16.44 (+0.12%)
F   12.80 (-1.84%)
MU   125.00 (-1.97%)
GE   156.17 (-0.78%)
CGC   8.17 (+0.25%)
DIS   115.69 (-1.25%)
AMC   2.75 (-1.79%)
PFE   26.25 (-0.34%)
PYPL   65.51 (-0.44%)
XOM   123.08 (+1.06%)

Viatris (VTRS) News Today

$11.43
-0.14 (-1.21%)
(As of 09:58 AM ET)
SourceHeadline
seekingalpha.com logoViatris Stock: Way Too Undervalued With $1 Billion Buyback Potential
seekingalpha.com - April 8 at 6:46 PM
reuters.com logoUK's Theramex sees no impact to HRT products supply after CMA probe
reuters.com - April 5 at 1:49 PM
msn.com logoViatris- Theramex deal for women's care products raises antitrust concerns in U.K.
msn.com - April 4 at 12:46 PM
benzinga.com logoViatris Stock (NASDAQ:VTRS), Quotes and News Summary
benzinga.com - April 2 at 10:56 PM
msn.com logoTeva and Viatris Granted Opportunity to Contest J&J’s Patent for Schizophrenia Drug
msn.com - April 2 at 7:34 AM
msn.com logoTeva and Viatris revives chance to dispute J&J's schizophrenia drug patent
msn.com - April 1 at 2:18 PM
reuters.com logoTeva, Viatris win new chance to challenge J&J schizophrenia drug patent
reuters.com - April 1 at 11:53 AM
stockhouse.com logoViatris Announces the Launch of RYZUMVl(TM) (Phentolamine Ophthalmic Solution) 0.75% in the United States
stockhouse.com - April 1 at 9:08 AM
finance.yahoo.com logoViatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States
finance.yahoo.com - April 1 at 9:08 AM
markets.businessinsider.com logoViatris Announces US Commercial Launch Of RYZUMVl 0.75%
markets.businessinsider.com - April 1 at 9:08 AM
seekingalpha.com logoViatris Stock Is Still Worth Buying
seekingalpha.com - March 30 at 8:13 AM
seekingalpha.com logoViatris Inc. (VTRS) R&D Event (Transcript)
seekingalpha.com - March 27 at 3:26 PM
finance.yahoo.com logoViatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline
finance.yahoo.com - March 27 at 8:10 AM
marketbeat.com logoViatris Q4 Earnings Transcript
marketbeat.com - March 20 at 7:00 AM
globenewswire.com logoIdorsia and Viatris successfully close the transaction for the global research and development collaboration
globenewswire.com - March 18 at 2:00 AM
ca.finance.yahoo.com logoVTRS Oct 2024 18.000 call
ca.finance.yahoo.com - March 16 at 6:37 AM
ca.finance.yahoo.com logoVTRS Oct 2024 10.000 put
ca.finance.yahoo.com - March 16 at 6:37 AM
finance.yahoo.com logoVTRS Jul 2024 18.000 call
finance.yahoo.com - March 16 at 6:37 AM
reuters.com logoViatris generic hypertension drug does not violate J&J patents, US court says
reuters.com - March 15 at 6:04 PM
fool.com logoIs Viatris a Great Dividend Stock or Just a Value Trap?
fool.com - March 14 at 9:53 AM
fool.com logo2 Dirt Cheap Dividend Stocks to Buy and Hold
fool.com - March 11 at 9:45 AM
reuters.com logoUS FDA declines to approve Viatris's injection for multiple sclerosis
reuters.com - March 11 at 7:32 AM
finance.yahoo.com logoViatris Inc. (NASDAQ:VTRS) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 5 at 11:26 AM
seekingalpha.com logoViatris Inc. (VTRS) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 1 at 9:33 AM
bizjournals.com logoViatris partners with pharmaceutical company to commercialize 2 products
bizjournals.com - February 28 at 2:47 PM
msn.com logoVTRS Earnings: Viatris’ Top Line Declines in Q4; Boosts Buybacks by $1b
msn.com - February 28 at 2:47 PM
investing.com logoIdorsia surges 14% after securing $350M from Viatris in an R&D pact
investing.com - February 28 at 9:46 AM
sfgate.com logoViatris: Q4 Earnings Snapshot
sfgate.com - February 28 at 9:46 AM
markets.businessinsider.com logoViatris Guides FY24 In Line With Estimates - Update
markets.businessinsider.com - February 28 at 9:46 AM
msn.com logoViatris EPS of -$0.64, revenue of $3.83B misses by $50M
msn.com - February 28 at 9:46 AM
msn.com logoViatris sets 2024 guidance above consensus; boosts share buybacks
msn.com - February 28 at 9:46 AM
finance.yahoo.com logoViatris Inc (VTRS) Meets 2023 Financial Targets and Sets Course for Continued Growth in 2024
finance.yahoo.com - February 28 at 9:46 AM
reuters.com logoViatris forecasts strong 2024 sales on higher demand for branded drugs
reuters.com - February 28 at 8:22 AM
prnewswire.com logoViatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
prnewswire.com - February 28 at 6:30 AM
prnewswire.com logoViatris and Idorsia Enter Into Significant Global Research and Development Collaboration
prnewswire.com - February 28 at 1:00 AM
globenewswire.com logoIdorsia and Viatris enter into a significant global research and development collaboration
globenewswire.com - February 28 at 1:00 AM
investorplace.com logo3 Overextended Stocks That Need to Slash Their Dividends ASAP
investorplace.com - February 27 at 3:19 PM
markets.businessinsider.com logoViatris is about to announce earnings — here's what Wall Street expects
markets.businessinsider.com - February 27 at 2:19 PM
msn.com logoViatris Q4 2023 earnings preview: Margins remain under pressure
msn.com - February 27 at 2:19 PM
investorplace.com logo3 Bargain Stocks to Snatch Up Before They Bounce Back
investorplace.com - February 26 at 4:27 PM
seekingalpha.com logoViatris Reduces Debt But Faces Growth Hurdles
seekingalpha.com - February 22 at 12:54 AM
msn.com logoViatris stock set for seven straight sessions of gains
msn.com - February 20 at 5:08 PM
msn.com logoSPY ETF Update, 2/20/2024
msn.com - February 20 at 12:06 PM
finance.yahoo.com logoVTRS Jan 2025 15.000 call
finance.yahoo.com - February 20 at 7:06 AM
finance.yahoo.com logoVTRS Oct 2024 12.000 call
finance.yahoo.com - February 20 at 2:05 AM
finance.yahoo.com logoVTRS Jan 2026 15.000 put
finance.yahoo.com - February 20 at 2:05 AM
finance.yahoo.com logoVTRS Mar 2024 12.000 call
finance.yahoo.com - February 19 at 9:55 AM
seekingalpha.com logoWall Street Breakfast: What Moved Markets
seekingalpha.com - February 18 at 8:34 AM
finance.yahoo.com logoVTRS Mar 2024 10.000 call
finance.yahoo.com - February 17 at 12:26 PM
msn.com logoSPY ETF Update, 2/16/2024
msn.com - February 16 at 4:25 PM
Get Viatris News Delivered to You Automatically

Sign up to receive the latest news and ratings for VTRS and its competitors with MarketBeat's FREE daily newsletter.

SHOCKING Altcoin Moves… (Ad)

Bitcoin's recent price boom has sent select altcoins into an absolute FRENZY! Which is why we've gathered 27 crypto experts to share their top picks and predictions as we rapidly approach the Bitcoin halving event this month…

Click here to register now

VTRS Media Mentions By Week

VTRS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VTRS
News Sentiment

0.57

0.61

Average
Medical
News Sentiment

VTRS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VTRS Articles
This Week

3

3

VTRS Articles
Average Week

Get Viatris News Delivered to You Automatically

Sign up to receive the latest news and ratings for VTRS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:VTRS) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners